发明授权
- 专利标题： Anti-IL-17 antibodies
- 专利标题（中）： 抗IL-17抗体
-
申请号： US12908892申请日： 2010-10-21
-
公开(公告)号： US08110191B2公开(公告)日： 2012-02-07
- 发明人: Barrett Allan , Chi-Kin Chow , Ling Liu , Jirong Lu , Jonathan Wendell Tetreault , Ying Tang
- 申请人： Barrett Allan , Chi-Kin Chow , Ling Liu , Jirong Lu , Jonathan Wendell Tetreault , Ying Tang
- 申请人地址： US IN Indianapolis
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： US IN Indianapolis
- 代理商 Gregory A. Cox
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/24
摘要：
Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
公开/授权文献
- US20110027290A1 ANTI-IL-17 ANTIBODIES 公开/授权日：2011-02-03
信息查询
